NSE filing, NSE: AMRUTANJAN. Summary written from the filing by ALFA Finder's alert engine.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹512.40
- Market cap
- ₹1,481 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 25.9×Sector 41.3×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Investor Presentation: Key Takeaways
Q2 FY27 net sales ₹135.2 Cr (+14.9%), PAT ₹17.3 Cr (+23.8%). H1 PAT ₹21.7 Cr, down 2.8% on cost pressure.
Amrutanjan Health Care Dividend
Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.
Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +23.6% YoY
Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Other credit rating announcements
All →I G Petrochemicals Credit Rating
India Ratings & Research affirmed and assigned IND AA-/Stable/IND A1+ to IG Petrochemicals' bank loan facilities. The rating signals sustained credit strength for the company's debt instruments.
Bank of Maharashtra Credit Rating
CRISIL reaffirmed its Crisil A1+ rating on Bank of Maharashtra's Certificate of Deposits. No new money is involved, only a rating action on existing securities.
DEE Development Engineers Credit Rating
DEE Development Engineers' bank facilities were upgraded by CARE Ratings to CARE A; Stable and CARE A2+/A1. Long-term facilities were reduced to Rs.169.19 crore, while combined and short-term limits were enhanced.
Subros Credit Rating
ICRA assigned or reaffirmed Subros's bank facility ratings, with total rated facilities rising from Rs.305 Crore to Rs.370 Crore. The long-term term loan rating is [ICRA]AA (Stable), raised to Rs.140 Crore from Rs.40 Crore.
Capital India Finance Credit Rating
Capital India Finance received a new ACUITE A- long-term rating with Stable outlook for its proposed NCDs. Acuite assigned it on 2 November 2026.
Deccan Cements Credit Rating
Infomerics withdrew its rating on Deccan Cements' proposed NCD issue after the proposal was dropped. The earlier August 2026 action was a downgrade to IVR BB+/Negative.